Medical food can be described as food that is intended to be consumed and provided by people with a variety of diseases for whom special nutritional needs based on accepted scientific principles are identified through a medical assessment. Furthermore, the increasing prevalence of chronic diseases, growing nutritional deficiency among people, and rising awareness about prebiotics and probiotic products are further expected to drive the growth of the Global Medical Foods Market during the forecast period. The major players have adopted a strategy of obtaining regulatory approval from government agencies for their devices and signing contracts and agreements to broaden their reach and reduce operational costs. For instance, in July 2022, Nestlé (Switzerland) introduced the First Foods for Special Medical Purpose (FSMP) Oral Impact Su Yi Su for patients with tumor-related conditions.
The Global Medical Foods Market is extremely competitive, with players competing, partnering, and investing heavily in R&D to gain a significant market share. The market is moderately fragmented with rising competition, product launches, and other strategic decisions to achieve operational efficiency.
The business model developed by manufacturers in the Global Medical Foods Market includes the manufacturing of medical foods. The growth of prominent industry players is dependent on various factors, such as market conditions, government support, and industry development. Key manufacturers of medical foods are also focusing on investing in R&D activities. This will boost market growth in the upcoming future.
With respect to the current scope of the report, Abbott (US) is the top player in the Global Medical Foods Market due to its strong product offering and high preference for its products by customers Nestlé (Switzerland) is the second major player, followed by Danone (France), Fresenius Kabi AG (Germany), and Reckitt Benckiser Group plc (UK). Other key players contributing to the market growth include Medtrition Inc (US), Primus Pharmaceuticals, Inc (US), Alfasigma USA, Inc (US), Medical Foods (US), and Metagenics LLC (US).
Threat of New Entrants
It is mandatory for companies that are trying to enter the market to accept and abide by the standards set by the Food and Drug Administration (FDA), the European Medicines Agency (EMA), the Central Drugs Standard Control Organization (CDSCO), and others. Moreover, it is certain that the new firm in the medical foods industry faces hindrances owing to the brand image of existing players such as Nestle S.A. (Switzerland) and Danone (France), the product suitability of existing brands with safety and efficacy, and the broad network of existing players with top hospitals, doctors, pharmacies, and other offline and online stores. However, there are several start-ups working to bring personalized medical food products owing to growing rates of obesity, heart disease, and diabetes without any adverse effects. Additionally, the exempt from getting pre-marketing approval for medical foods, decreasing the barrier to entry to some extent, proving that the threat of new entrants in this market to be moderate.
Bargaining Power of Suppliers
The market players are huge, and at the same time, the consumers are also large owing to the high incidences of chronic diseases across the globe, including heart disease, cancer, respiratory disease, and diabetes. Moreover, researchers revealed that continuously using a medical food product may lead to the development of resistance in the body. Further, the low-price differences among the market players in the market enable consumers to easily switch products. Also, the number of suppliers is large owing to the availability of the huge patient pool, making it difficult for the supplier to establish themselves in the market. Therefore, the deciding factor is the quality of outcomes the products provide. Hence, the bargaining power of suppliers in the Global Medical Foods Market is moderate during the forecast period.
Threat of Substitutes
Substitutes pose a moderate threat in the Global Medical Foods Market due to the availability of substitutes for medical foods such as over-the-counter nutritional supplements. As well, there are price differences among the medical food products of different market players; however, consumers' high demand for the same brand is high owing to the brand's image of the product with safety and efficacy. There are a huge number of market players, and the number of consumers is also high; however, the well-known products to the physicians that seem best at curing any chronic diseases will increase the demand for the same product. Additionally, the lack of awareness among end consumers and lack of the ability to differentiate between medical foods and supplements further increases the threat of supplements. Therefore, the threat of substitutes in the Global Medical Foods Market is high.
Bargaining Power of Buyers
The low number of manufacturers as compared to the number of consumers puts buyers under pressure to buy the medical foods product because demand for the same brand is high. There are other medical foods available in the market from competitors with a lower price; however, when it comes to efficacy and safety, physicians and patients both prefer products from few brands only, which increases the demand for the same brand. Furthermore, there will be no brand switching because the medical products will be given based on patient suitability and diseases and assist in curing diseases. Thus, the bargaining power of buyers is projected to be low in the Global Medical Foods Market during the forecast period.
Intensity of Rivalry
A huge number of products are available that can assist in curing a single disease, owing to a large number of suppliers. The demand for food products is high owing to the increasing number of sports players, rising rates of chronic diseases, and growing awareness of the importance of keeping health a priority. As well, there are price differences among the products of the players in the medical food market that provide the same efficacy, which means there may be high chances of brand switching. There is a larger number of market players and products available in the market, and consumers are also in high numbers, which puts manufacturers under pressure to launch a type of product with a comparable price and high efficacy, which shows that the competition seems high. Hence, the overall level of competition among players is high.
